Validation of ACR/EULAR Definition of Remission in Rheumatoid Arthritis From RA Practice: The ESPOIR Cohort

Arthritis Research and Therapy - United Kingdom
doi 10.1186/ar3896
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Let’s Not Fool Ourselves. In RA, the ACR/EULAR Remission Criteria Are Not Perfect!

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2016English

Silent Progression in Patients With Rheumatoid Arthritis: Is DAS28 Remission an Insufficient Goal in RA? Results From the German Remission-Plus Cohort

BMC Musculoskeletal Disorders
RheumatologyOrthopedicsSports Medicine
2017English

Diagnostic Accuracy of the 2002 EULAR Criteria for the Clinical Suspicion of Rheumatoid Arthritis and the Sensitivity of the New 2010 ACR/EULAR Classification Criteria in “Early Arthritis”

Turkish Journal of Rheumatology
2011English

New ACR/EULAR 2010 Classification Criteria for Rheumatoid Arthritis: A Step Forward in Its Early Diagnosis

Nauchno-Prakticheskaya Revmatologiya
RheumatologyAllergyImmunology
2011English

The Definition of Rheumatoid Arthritis

BMJ
1929English

Access to Immunological Markers for the Management of Rheumatoid Arthritis in Togo With Regard to 2010 ACR/EULAR Classification

MOJ Immunology
2017English

Finalisation and Validation of the Rheumatoid Arthritis Impact of Disease Score, a Patient-Derived Composite Measure of Impact of Rheumatoid Arthritis: A EULAR Initiative

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2011English

AB1047 Can the Acr/Eular 2010 Classification Criteria Be Used as Diagnostic Tool for Rheumatoid Arthritis in Real Life?

2017English

Serum Level of Adiponectin Is a Surrogate Independent Biomarker of Radiographic Disease Progression in Early Rheumatoid Arthritis: Results From the ESPOIR Cohort

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy